Author:
Thurberg Beth L.,Diaz George A.,Lachmann Robin H.,Schiano Thomas,Wasserstein Melissa P.,Ji Allena J.,Zaher Atef,Peterschmitt M. Judith
Funder
Sanofi Genzyme.
Sanofi Genzyme's Clinical Development
Clinical and Exploratory Pharmacology
Department of Pathology
Subject
Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference37 articles.
1. Plasma sphingomyelin level as a risk factor for coronary artery disease;Jiang;Arterioscler. Thromb. Vasc. Biol.,2000
2. Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease;Schlitt;Nutr. Metab. (Lond.),2006
3. Association of plasma sphingomyelin levels and incident coronary heart disease events in an adult population: multi ethnic study of atherosclerosis;Yeboah;Arterioscler. Thromb. Vasc. Biol.,2010
4. Schuchman, E.H., and Desnick, R.J. 2013. Niemann-Pick Disease Types a and B: Acid Sphingomyelinase Deficiencies. In OMMBID-The Online Metabolic and Molecular Bases of Inherited Disease. D. Valle, A. Beaudet, B. Vogelstein, K. Kinzler, S. Antonarakis, A. Ballabio, K. Gibson, and G. Mitchell, editors. New York: McGraw Hill. http://ommbid.mhmedical.com/content.aspx?bookid=474&Sectionid=45374145. Accessed May 2015.
5. Plasma lipoproteins: genetic influences and clinical implications;Hegele;Nat. Rev Genet.,2009
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献